Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimenrix vs Mencevax ACWY in Healthy Adults ≥56 Years
NCT01235975Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2010
- Primary completion
- Jul 2011
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of meningococcal group A, C, W135 and Y conjugate vaccine in meningococcal infection, sponsored by GSK. Started Nov 2010; status: completed.
02
Drugs
meningococcal group A, C, W135 and Y conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT01235975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01235975.